{"gene":"PAF1","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":2002,"finding":"PAF1 (Paf1) and Leo1 are components of the RNA polymerase II-associated Paf1 complex, which physically interacts with transcription elongation factors Spt4-Spt5 and Spt16-Pob3 (yeast FACT). Genetic and physical interactions were demonstrated, and loss of Paf1 complex function causes 6-azauracil sensitivity and diminished PUR5 induction, consistent with impaired transcription elongation.","method":"Affinity purification, mass spectrometry, Co-IP, genetic suppressor screen, 6-azauracil sensitivity assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP and genetic epistasis, replicated across multiple approaches in same study, foundational complex characterization","pmids":["11927560"],"is_preprint":false},{"year":2002,"finding":"Ctr9, Rtf1, and Leo1 are components of the yeast Paf1 complex associated with Pol II but not Srb-mediator. Deletion of PAF1 or CTR9 causes severe pleiotropic phenotypes; deletion of LEO1 or RTF1 suppresses many paf1Δ phenotypes (e.g., restoring CLN1 expression), indicating Paf1 complex integrity is required for normal transcription.","method":"Tandem affinity purification, mass spectrometry, genetic double-mutant analysis, gene expression assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — TAP-MS complex identification plus genetic epistasis in multiple double mutants, orthogonal methods","pmids":["11884586"],"is_preprint":false},{"year":2004,"finding":"The yeast Paf1 complex (Paf1, Ctr9, Cdc73, Rtf1, Leo1) travels with Pol II on chromatin at promoters and coding regions of active genes. Loss of Paf1 reduces Pol II Ser2 phosphorylation and shortens poly(A) tails. Loss of Rtf1 or Cdc73 dissociates the Paf1 complex from Pol II and chromatin, yet remaining complex members stay stably associated with each other. The major functions of Paf1 can therefore operate independently of actively transcribing Pol II.","method":"Chromatin immunoprecipitation (ChIP), functional tagging, poly(A) tail analysis, fractionation","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-based localization with functional consequence (Ser2 phosphorylation, poly(A) tails) plus multiple genetic backgrounds, multiple orthogonal methods","pmids":["15149594"],"is_preprint":false},{"year":2005,"finding":"Human PAF1 physically interacts with the tumor suppressor parafibromin (HRPT2 product) and with LEO1 and CTR9, forming a complex that also associates with Ser5- and Ser2-phosphorylated forms of the RNA Pol II large subunit CTD. This interaction depends on a C-terminal domain of parafibromin deleted in ~80% of clinically relevant mutations.","method":"Co-immunoprecipitation, RNAi knockdown, co-localization","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with multiple PAF1C subunits, domain-deletion mapping, functional cell-cycle readout","pmids":["15923622"],"is_preprint":false},{"year":2006,"finding":"Drosophila Paf1 colocalizes with phosphorylated (actively transcribing) Pol II on polytene chromosomes and is recruited to activated heat shock genes. RNAi depletion of Paf1 impairs Hsp70 RNA induction, reduces trimethylation of histone H3K4 at the Hsp70 promoter, and significantly decreases recruitment of chromatin factors Spt6 and FACT, revealing a role for Paf1 in modulating chromatin structure during active transcription.","method":"RNAi, chromatin immunoprecipitation (ChIP), immunofluorescence on polytene chromosomes, RNA assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — RNAi loss-of-function with multiple phenotypic readouts (RNA levels, histone marks, factor recruitment) plus ChIP, replicated in metazoan model","pmids":["16354696"],"is_preprint":false},{"year":2008,"finding":"The Paf1 complex directly interacts with the cleavage and polyadenylation factor Cft1. This interaction normally requires the Pol II-associated form of Paf1C; when Paf1C is dissociated from Pol II (by loss of Rtf1 or Cdc73), a direct Cft1–Paf1C interaction becomes detectable. Loss of Paf1, Ctr9, Cdc73, or Rtf1 reduces Pol II Ser2 phosphorylation and increases read-through of a polyadenylation site, supporting a role for Paf1C in recruiting 3'-end processing factors.","method":"Co-immunoprecipitation, functional tagging, polyadenylation read-through assay, Pol II CTD phosphorylation assay","journal":"Eukaryotic cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying direct Cft1–Paf1C interaction, coupled with functional 3'-end processing readouts, multiple subunit deletions tested","pmids":["18469135"],"is_preprint":false},{"year":2009,"finding":"PAF1/PD2 (the human homolog of Paf1) is overexpressed in mouse embryonic stem cells (ESCs), interacts physically with Oct3/4 and RNA Pol II, and is required for maintenance of ESC self-renewal. Knockdown or knockout of PAF1 reduces Oct3/4, SOX2, Nanog, and Shh levels, increases apoptosis, decreases S-phase fraction, and promotes endodermal differentiation markers.","method":"Co-immunoprecipitation, siRNA/shRNA knockdown, knockout ESCs, flow cytometry, gene expression analysis","journal":"Stem cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for Oct3/4 interaction, KO/KD with defined cellular phenotypes, single lab","pmids":["19821493"],"is_preprint":false},{"year":2011,"finding":"PAF1 (hPaf1/PD2) knockdown in pancreatic cancer cells reduces di- and tri-methylation of histone H3K4. PAF1 colocalizes with the H3K4 methyltransferase MLL1; reduction of PAF1 decreases MLL1 expression and reduces nuclear localization of the chromatin remodeling enzyme CHD1 (which reads H3K4me2/3 marks). PAF1 physically interacts with CHD1, and ectopic PAF1 expression rescues CHD1 nuclear localization, demonstrating PAF1 regulation of chromatin remodeling via H3K4 methylation.","method":"siRNA knockdown, Co-immunoprecipitation, confocal co-localization, micrococcal nuclease digestion, Western blot","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for PAF1-CHD1 interaction, KD with histone modification and chromatin structure readouts, rescue experiment, single lab","pmids":["22046413"],"is_preprint":false},{"year":2013,"finding":"The crystal structure of the human PAF1/LEO1 subcomplex reveals a tightly associated heterodimer formed through antiparallel beta-sheet interactions. LEO1 associates with the PAF1 complex through PAF1, and CTR9 is the key scaffold protein for overall PAF1C assembly. The PAF1/LEO1 heterodimer binds histone H3, the histone octamer, and the nucleosome in vitro.","method":"X-ray crystallography, biochemical binding assays (pull-down with histones/nucleosomes), deletion analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure plus in vitro reconstitution of histone binding, multiple orthogonal biochemical experiments in single study","pmids":["24038468"],"is_preprint":false},{"year":2014,"finding":"H2B K34 ubiquitylation by the MOF-MSL complex acts in early transcription elongation. PAF1, MSL, and RNF20/40 complexes are recruited and stabilized at active gene promoters through direct binary interactions. These complexes regulate chromatin association of pTEFb through a positive feedback loop, facilitating Pol II transition during early elongation.","method":"Co-immunoprecipitation (binary interactions), ChIP-seq, siRNA knockdown, RNA Pol II processivity assay","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for direct binary interactions, genome-wide ChIP-seq, functional elongation readouts, single lab","pmids":["24837678"],"is_preprint":false},{"year":2015,"finding":"PAF1 possesses an evolutionarily conserved function in metazoans in regulating RNA Pol II promoter-proximal pausing. Reduction in PAF1 levels leads to increased release of paused Pol II into gene bodies at thousands of genes, increased nascent and mature transcripts, and increased Pol II CTD Ser2 phosphorylation. This is mechanistically explained by increased recruitment of the Ser2-kinase super elongation complex (SEC) upon PAF1 depletion.","method":"siRNA depletion, GRO-seq (global run-on sequencing), ChIP-seq, RNA-seq","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide nascent transcription and ChIP-seq in human cells, mechanistic link to SEC/Ser2P, multiple orthogonal methods, high-impact journal","pmids":["26279188"],"is_preprint":false},{"year":2015,"finding":"The Paf1 complex (Paf1C) in fission yeast prevents RNAi-directed heterochromatin formation by promoting efficient transcription termination and rapid release of nascent RNA from the site of transcription. In Paf1C mutants, synthetic hairpin RNA can trigger stable, heritable heterochromatin at homologous loci through secondary siRNA production. Compromised transcription termination is sufficient to initiate bistable heterochromatin, but impairment of both termination and nascent transcript release is required for stability.","method":"Genetic screen, heterochromatin reporter assays, RNA-seq, ChIP, epistasis analysis in fission yeast","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic and biochemical approaches, mechanistic model with defined epistatic relationships, high-impact journal","pmids":["25807481"],"is_preprint":false},{"year":2015,"finding":"Leo1 and Paf1 (subcomplex of PAF1C) are required to prevent spreading of heterochromatin into euchromatin in fission yeast. Loss of Leo1 decreases nucleosome turnover, leading to heterochromatin stabilization at facultative heterochromatin loci, in an RNAi-independent manner.","method":"Random mutagenesis screen, ChIP-exo (genome-wide H3K9me2 mapping), histone turnover assay","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-exo and histone turnover assays with genetic KO, single lab, mechanistic link to chromatin state maintenance","pmids":["26518661"],"is_preprint":false},{"year":2017,"finding":"PAF1 occupies transcriptional enhancers and restrains hyperactivation of a subset of them. PAF1 loss leads to enhancer activation, which in turn releases Pol II from paused promoters of nearby PAF1 target genes. Knockout of PAF1-regulated enhancers attenuates release of paused Pol II from cognate promoters without major effects on pausing establishment.","method":"ChIP-seq, CRISPR enhancer knockout, GRO-seq, nascent RNA assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR enhancer KO combined with ChIP-seq and GRO-seq, multiple orthogonal approaches establishing enhancer-PAF1-pausing mechanistic axis","pmids":["28860207"],"is_preprint":false},{"year":2017,"finding":"Paf1 level on Pol II varies between genes, is dynamically controlled via promoters by environmental factors, and correlates with levels of transcript processing and export factors on the encoded RNA. High Paf1 levels on Pol II promote nuclear export of transcripts, while low levels correlate with nuclear retention. Loss of Paf1 causes marked transcription elongation defects, but low levels are sufficient for elongation.","method":"Native elongating transcript sequencing (NET-seq), strand-specific nucleotide-resolution RNA analysis, yeast genetics","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — nucleotide-resolution elongation assay, multiple mutant strains, mechanistic distinction between elongation and transcript fate functions","pmids":["28190769"],"is_preprint":false},{"year":2017,"finding":"Drosophila PAF1 antagonizes PIWI/piRNA-directed gene silencing. PAF1 knockdown enhances PIWI silencing of reporters when piRNAs target transcript regions proximal to the promoter. Loss of PAF1 suppresses endogenous transposable element transcript maturation, suggesting PAF1 acts mechanistically downstream of initial PIWI silencing events in a manner conserved with fission yeast Paf1C opposing AGO1/siRNA silencing.","method":"RNAi in Drosophila OSS cells, piRNA-targeted reporter assay, transposable element expression analysis","journal":"Current biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — RNAi with defined reporter readout and TE expression, single lab, single model system","pmids":["28844648"],"is_preprint":false},{"year":2018,"finding":"PAF1 interacts with PHF5A and DDX3 in pancreatic cancer stem cells (CSCs), independently of its role as a PAF1 complex (PAF1C) component. The PAF1-PHF5A-DDX3 sub-complex binds to the promoter of Nanog and regulates stemness gene expression. Knockdown of PAF1 reduces CSC markers (NANOG, SOX9, β-CATENIN, CD44v6, ALDH1), tumor sphere formation, and orthotopic tumor growth. DDX3 inhibitor RK-33 reduces PAF1-DDX3-Nanog promoter binding and CSC self-renewal.","method":"Co-immunoprecipitation, mass spectrometry, ChIP-seq, CRISPR/Cas9 KO, shRNA KD, orthotopic tumor model, flow cytometry","journal":"Gastroenterology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP/MS for interaction, ChIP-seq for promoter binding, KO/KD with functional readouts, single lab","pmids":["32781084"],"is_preprint":false},{"year":2018,"finding":"Crystal structures of both human and yeast Ctr9/Paf1 subcomplexes reveal heterodimers with similar conformations, with an interface between the tetratricopeptide repeat (TPR) module of Ctr9 and Paf1. Formation of the Ctr9/Paf1 heterodimer is required for Paf1C assembly and yeast viability. Disruption of the Ctr9-Paf1 interaction greatly reduces histone H3 methylation in vivo.","method":"X-ray crystallography (human and yeast), biochemical assembly assays, yeast viability assays, histone modification analysis in vivo","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures for two species, biochemical reconstitution, viability and histone modification functional validation in multiple organisms","pmids":["30228257"],"is_preprint":false},{"year":2019,"finding":"PAF1C (specifically Paf1 and Leo1 subunits) selectively promotes transcription of long, toxic GGGGCC repeat expansions (≥30 repeats) in C9orf72-associated FTD/ALS but not shorter, nontoxic repeats in Drosophila. PAF1C depletion reduces both repeat RNA and GR dipeptide production. LEO1 binds C9+ repeat chromatin in human C9+ FTD cells, and PAF1C is upregulated following long repeat expression.","method":"Drosophila genetic screen (unbiased), RNA quantification, ChIP (LEO1 binding to C9+ chromatin), transgenic models","journal":"Nature neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — unbiased genetic screen plus ChIP validation in human cells, multiple organisms, single lab","pmids":["31110321"],"is_preprint":false},{"year":2019,"finding":"The Paf1 complex (Paf1C) acts as a transcriptional repressor of ATG32 in yeast, suppressing mitophagy under glucose-rich conditions. Deletion of PAF1 or CTR9 increases ATG32 and ATG11 expression and facilitates mitophagy. Paf1C binds the ATG32 promoter; glucose starvation triggers dissociation of Paf1C from ATG32, de-repressing it. This mitophagic role is independent of Paf1C's positive regulatory functions and is conserved in mammals.","method":"ChIP (Paf1C binding to ATG32 promoter), gene deletion, RT-qPCR, mitophagy assays, mammalian validation","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct promoter binding, genetic KO with functional mitophagy readout, mammalian conservation shown, single lab","pmids":["31525119"],"is_preprint":false},{"year":2021,"finding":"Dengue virus NS5 physically interacts with PAF1C (requiring NS5 nuclear localization and the C-terminal region of its methyltransferase domain) and antagonizes PAF1C recruitment to immune response genes. PAF1 knockout enhances DENV2 virion production. PAF1 is required for expression of STAT2-independent immune response genes, defining a distinct antiviral pathway.","method":"Co-immunoprecipitation, NS5 mutant analysis, PAF1 CRISPR KO, RNA-seq, viral titer assay","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain mapping, KO with viral replication and transcriptome readouts, single lab","pmids":["34797876"],"is_preprint":false},{"year":2022,"finding":"PAF1 governs Pol II promoter-proximal pausing partially by recruiting Integrator-PP2A (INTAC) complex. Acute PAF1 degradation (using rapid degron system) causes most destabilized Pol II to undergo effective release, resulting from skewed balance between INTAC and P-TEFb and leading to hyperphosphorylated SPT5. PAF1 also ensures productive elongation progression. PAF1 degradation causes cumulative decline in histone modifications, further influencing transcriptional output.","method":"Rapid degron system (acute degradation), ChIP-seq, GRO-seq, mass spectrometry, phospho-proteomics","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — acute degradation system (avoids adaptation), genome-wide ChIP-seq and GRO-seq, phospho-proteomics, multiple orthogonal approaches","pmids":["35363521"],"is_preprint":false},{"year":2022,"finding":"PAF1C promotes 3' processing (cleavage and termination) of pervasive transcripts (eRNAs and PROMPTs) by facilitating Integrator complex recruitment to sites of pervasive transcript cleavage 1-3 kb downstream of TSSs. PAF1C also recruits Integrator to coding genes but dissociates from Integrator upon entry into processive elongation.","method":"PAF1C depletion (siRNA/degradation), PRO-seq, ChIP-seq, co-immunoprecipitation","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for PAF1C-Integrator interaction, depletion with functional cleavage and termination readouts, single lab","pmids":["35294889"],"is_preprint":false},{"year":2023,"finding":"The Rtf1 subunit of Paf1C directly interacts with the highly conserved N-terminal helix of the ubiquitin conjugase Rad6 through Rtf1's histone modification domain (HMD). This interaction stimulates H2B K123 ubiquitylation (H2BK123ub) in vivo and in vitro. Separation-of-function RAD6 mutations that impair the Rad6-HMD interface greatly reduce H2BK123ub but not other Rad6 functions, and yield transcriptome profiles matching an H2B ubiquitylation site mutant.","method":"In vitro cross-linking/mass spectrometry (interaction mapping), in vitro ubiquitylation assay, yeast genetics (separation-of-function mutants), RNA-seq, in vivo protein cross-linking","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of ubiquitylation, cross-linking MS for contact mapping, multiple separation-of-function alleles, transcriptome validation, multiple orthogonal methods","pmids":["37216505"],"is_preprint":false},{"year":2012,"finding":"Paf1C in Saccharomyces cerevisiae is broadly required for snoRNA 3'-end formation, functioning with RNA-binding proteins Nrd1 and Nab3. Regulation is locus-specific: different Paf1-dependent histone modifications (H2B monoubiquitylation via Rad6, H3K36me2 via Set2) are required at different snoRNA loci. At some snoRNAs, Rad6 function in 3'-end formation is largely independent of its H2B ubiquitylation activity.","method":"High-density tiling arrays (transcriptome-wide), ChIP, genetic deletions, epistasis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide tiling array analysis plus targeted ChIP and genetics, single lab","pmids":["23109428"],"is_preprint":false}],"current_model":"PAF1 is the core subunit of the conserved RNA Pol II-associated PAF1 complex (PAF1C), which travels with Pol II through the transcription cycle and regulates promoter-proximal pausing (by recruiting Integrator-PP2A and restraining super elongation complex access), transcription elongation, histone modifications (H3K4 methylation via MLL1/Set1; H2B ubiquitylation via Rtf1-Rad6 interaction), chromatin structure (nucleosome turnover), 3'-end processing/termination of mRNAs, snoRNAs, and pervasive transcripts (via Cft1 and Integrator recruitment), and epigenetic silencing (preventing RNAi-directed heterochromatin spreading); additionally, PAF1 physically interacts with Oct3/4 to maintain embryonic stem cell self-renewal and, independently of PAF1C, forms a sub-complex with PHF5A and DDX3 to regulate Nanog expression in cancer stem cells."},"narrative":{"mechanistic_narrative":"PAF1 is the core subunit of the conserved RNA polymerase II-associated PAF1 complex (PAF1C; Paf1, Ctr9, Cdc73/parafibromin, Rtf1, Leo1), which travels with Pol II across promoters and coding regions of active genes and couples transcription elongation to chromatin modification and RNA 3'-end processing [PMID:11927560, PMID:11884586, PMID:15149594, PMID:15923622]. Structurally, PAF1 nucleates assembly through a tightly intertwined Ctr9/Paf1 heterodimer and a Paf1/Leo1 heterodimer that together bind histone H3, the octamer, and the nucleosome; loss of the Ctr9-Paf1 interface abolishes complex assembly and histone H3 methylation in vivo [PMID:24038468, PMID:30228257]. PAF1C directs co-transcriptional histone marks—H3K4 methylation via MLL1/Set1 and Rtf1-stimulated Rad6-dependent H2B K123 ubiquitylation—and modulates nucleosome dynamics and recruitment of Spt6/FACT during active transcription [PMID:16354696, PMID:22046413, PMID:30228257, PMID:37216505]. In metazoans PAF1 is a central regulator of Pol II promoter-proximal pausing, restraining release into gene bodies by limiting super elongation complex (SEC) access and by recruiting the Integrator-PP2A (INTAC) complex to skew the balance against P-TEFb-driven SPT5 phosphorylation [PMID:26279188, PMID:35363521]; this pausing control extends to enhancers, where PAF1 restrains hyperactivation that would otherwise release paused Pol II at target promoters [PMID:28860207]. PAF1C also promotes 3'-end processing and termination of mRNAs, snoRNAs, and pervasive transcripts (eRNAs/PROMPTs) through interactions with cleavage/polyadenylation factor Cft1 and Integrator [PMID:18469135, PMID:35294889, PMID:23109428], and by ensuring efficient termination and nascent-transcript release it prevents RNAi/piRNA-directed heterochromatin spreading [PMID:25807481, PMID:26518661, PMID:28844648]. Beyond canonical PAF1C functions, PAF1 maintains embryonic stem cell self-renewal through physical interaction with Oct3/4 [PMID:19821493] and, independently of PAF1C, forms a PHF5A-DDX3 sub-complex that binds the Nanog promoter to drive cancer stem cell programs [PMID:32781084].","teleology":[{"year":2002,"claim":"Established PAF1 as the defining subunit of a Pol II-associated complex distinct from Srb-mediator, answering whether PAF1 acts on transcription and through what assembly.","evidence":"Affinity/TAP purification with mass spectrometry, reciprocal Co-IP, and genetic epistasis with elongation factors in yeast","pmids":["11927560","11884586"],"confidence":"High","gaps":["Direct mechanistic step in elongation not yet defined","Functional consequence on specific histone marks not yet established"]},{"year":2004,"claim":"Showed PAF1C physically travels with Pol II on active genes and influences CTD Ser2 phosphorylation and poly(A) tail length, linking the complex to both elongation and RNA fate.","evidence":"ChIP localization, poly(A) tail analysis, and fractionation across subunit-deletion backgrounds in yeast","pmids":["15149594"],"confidence":"High","gaps":["Whether Ser2P change is direct or indirect unresolved","Mechanism coupling Paf1C to poly(A) machinery not defined"]},{"year":2005,"claim":"Extended PAF1C to humans and tied it to the tumor suppressor parafibromin, connecting the complex to a clinically mutated subunit.","evidence":"Reciprocal Co-IP, RNAi, domain-deletion mapping, and CTD phospho-form association in human cells","pmids":["15923622"],"confidence":"High","gaps":["Disease-causing mechanism of parafibromin loss not established here","Direct enzymatic activity not addressed"]},{"year":2006,"claim":"Defined a metazoan role in chromatin modulation during active transcription, showing PAF1 is required for H3K4me3 and Spt6/FACT recruitment at induced genes.","evidence":"RNAi depletion with ChIP, polytene immunofluorescence, and RNA induction assays in Drosophila","pmids":["16354696"],"confidence":"High","gaps":["Direct vs. indirect effect on H3K4me3 unresolved","Whether PAF1 recruits the methyltransferase directly not shown"]},{"year":2008,"claim":"Mechanistically linked PAF1C to 3'-end processing via a direct Cft1 interaction, explaining polyadenylation read-through phenotypes.","evidence":"Co-IP detecting Cft1-Paf1C interaction and read-through/CTD phospho assays across subunit deletions in yeast","pmids":["18469135"],"confidence":"High","gaps":["Why interaction is masked on Pol II-bound Paf1C not fully explained","Generality across genes not tested genome-wide here"]},{"year":2009,"claim":"Connected PAF1 to pluripotency, showing it interacts with Oct3/4 and sustains ESC self-renewal.","evidence":"Co-IP, knockdown/knockout ESCs, flow cytometry, and pluripotency gene expression analysis","pmids":["19821493"],"confidence":"Medium","gaps":["Whether the Oct3/4 effect requires PAF1C integrity not resolved","Single lab; direct chromatin targets at pluripotency genes not mapped"]},{"year":2011,"claim":"Linked PAF1 to chromatin remodeling output by showing it supports MLL1-dependent H3K4 methylation and CHD1 nuclear localization in cancer cells.","evidence":"siRNA knockdown, Co-IP, confocal co-localization, MNase digestion, and rescue in pancreatic cancer cells","pmids":["22046413"],"confidence":"Medium","gaps":["Directness of PAF1-MLL1 regulation not established","Single lab and cell-type specific"]},{"year":2012,"claim":"Generalized PAF1C 3'-processing function to snoRNAs, showing locus-specific dependence on distinct PAF1-controlled histone marks acting with Nrd1/Nab3.","evidence":"Transcriptome-wide tiling arrays, ChIP, and epistasis with deletion strains in yeast","pmids":["23109428"],"confidence":"Medium","gaps":["Basis of locus-specific mark requirement unexplained","Some Rad6 effects uncoupled from H2Bub mechanistically unclear"]},{"year":2013,"claim":"Provided structural basis for assembly and nucleosome engagement, defining the PAF1/LEO1 heterodimer and CTR9 as scaffold.","evidence":"X-ray crystallography of human PAF1/LEO1 plus in vitro histone/nucleosome binding assays","pmids":["24038468"],"confidence":"High","gaps":["Functional consequence of nucleosome binding in vivo not shown","Full-complex architecture not resolved here"]},{"year":2014,"claim":"Placed PAF1 in an H2BK34ub-dependent positive feedback loop stabilizing chromatin factors and pTEFb during early elongation.","evidence":"Co-IP binary-interaction mapping, ChIP-seq, siRNA, and Pol II processivity assays","pmids":["24837678"],"confidence":"Medium","gaps":["Direct vs. cooperative recruitment not fully separated","Single lab"]},{"year":2015,"claim":"Established PAF1 as a conserved regulator of promoter-proximal pausing that restrains SEC-driven pause release, distinguishing pausing control from elongation per se.","evidence":"siRNA depletion with GRO-seq, ChIP-seq, and RNA-seq in human cells","pmids":["26279188"],"confidence":"High","gaps":["How PAF1 limits SEC recruitment mechanistically not fully defined here","Locus determinants of pausing sensitivity unclear"]},{"year":2015,"claim":"Defined a chromatin-protective role in which PAF1C-driven termination and transcript release prevent RNAi-directed and spreading heterochromatin.","evidence":"Genetic screens, heterochromatin reporters, RNA-seq, ChIP/ChIP-exo, and histone turnover assays in fission yeast","pmids":["25807481","26518661"],"confidence":"High","gaps":["Molecular step coupling release to RNAi suppression not fully resolved","Relevance to metazoan heterochromatin not tested here"]},{"year":2017,"claim":"Distinguished elongation from RNA-fate roles by showing Paf1 occupancy is dynamic and promoter-tuned, coupling high occupancy to nuclear export.","evidence":"NET-seq at nucleotide resolution with yeast genetics across mutant strains","pmids":["28190769"],"confidence":"High","gaps":["Mechanism linking Paf1 level to export factor loading not defined","How promoters set Paf1 occupancy unknown"]},{"year":2017,"claim":"Extended PAF1 pausing control to enhancers, showing it restrains enhancer hyperactivation that drives pause release at cognate promoters.","evidence":"ChIP-seq, CRISPR enhancer knockout, and GRO-seq in human cells","pmids":["28860207"],"confidence":"High","gaps":["How PAF1 represses enhancer activity mechanistically not defined","Selectivity for enhancer subsets unexplained"]},{"year":2017,"claim":"Demonstrated conservation of PAF1's antagonism of small-RNA-directed silencing, here against PIWI/piRNA pathways downstream of initial silencing.","evidence":"RNAi with piRNA-targeted reporters and transposable-element expression in Drosophila OSS cells","pmids":["28844648"],"confidence":"Medium","gaps":["Single model and lab","Precise step downstream of PIWI not pinpointed"]},{"year":2018,"claim":"Revealed a PAF1C-independent oncogenic function: a PAF1-PHF5A-DDX3 sub-complex binds the Nanog promoter to sustain cancer stem cells.","evidence":"Co-IP/MS, ChIP-seq, CRISPR KO, shRNA, orthotopic tumor models, and DDX3 inhibitor in pancreatic CSCs","pmids":["32781084"],"confidence":"Medium","gaps":["Structural basis of the sub-complex unknown","Single lab; generality across tumor types untested"]},{"year":2018,"claim":"Implicated PAF1C in selectively transcribing toxic GGGGCC repeat expansions, connecting it to C9orf72 FTD/ALS pathology.","evidence":"Unbiased Drosophila genetic screen, RNA/dipeptide quantification, and LEO1 ChIP in human C9+ cells","pmids":["31110321"],"confidence":"Medium","gaps":["Why long repeats are selectively favored not mechanistically resolved","Single lab"]},{"year":2019,"claim":"Uncovered a repressive PAF1C function: promoter-bound Paf1C represses ATG32 to suppress mitophagy until glucose starvation triggers its dissociation.","evidence":"ChIP of promoter binding, gene deletions, RT-qPCR, mitophagy assays with mammalian validation","pmids":["31525119"],"confidence":"Medium","gaps":["Signal coupling starvation to Paf1C dissociation unknown","Mechanism of repression at the promoter undefined"]},{"year":2021,"claim":"Defined an antiviral role and a viral evasion mechanism, with Dengue NS5 binding PAF1C to block its recruitment to STAT2-independent immune genes.","evidence":"Co-IP with NS5 domain mapping, PAF1 CRISPR KO, RNA-seq, and viral titer assays","pmids":["34797876"],"confidence":"Medium","gaps":["How NS5 displaces PAF1C from chromatin not resolved","Breadth of immune gene set incompletely mapped"]},{"year":2022,"claim":"Mechanistically resolved the pausing function via acute degradation, showing PAF1 recruits INTAC to balance against P-TEFb and limits SPT5 hyperphosphorylation.","evidence":"Rapid degron, ChIP-seq, GRO-seq, mass spectrometry, and phospho-proteomics in human cells","pmids":["35363521"],"confidence":"High","gaps":["How PAF1 physically delivers INTAC to paused Pol II not fully defined","Relative contribution of histone-mark loss vs. direct effects unresolved"]},{"year":2022,"claim":"Showed PAF1C promotes Integrator-dependent 3' cleavage/termination of pervasive transcripts and dissociates from Integrator upon processive elongation.","evidence":"PAF1C depletion/degradation with PRO-seq, ChIP-seq, and Co-IP in human cells","pmids":["35294889"],"confidence":"Medium","gaps":["Switch controlling Integrator handoff at elongation entry undefined","Single lab"]},{"year":2023,"claim":"Resolved the molecular basis of PAF1C-driven H2B ubiquitylation, mapping a direct Rtf1-HMD/Rad6 contact that stimulates H2BK123ub.","evidence":"Cross-linking/MS, in vitro ubiquitylation, separation-of-function RAD6 alleles, and RNA-seq in yeast","pmids":["37216505"],"confidence":"High","gaps":["How H2Bub feeds into downstream elongation/termination not fully traced","Structural model of the Rtf1-Rad6-nucleosome complex absent"]},{"year":null,"claim":"It remains unresolved how PAF1 physically integrates its dual roles—delivering INTAC/3'-processing factors versus restraining SEC—into a single dynamic occupancy program across the transcription cycle, and how PAF1C-independent sub-complexes are partitioned mechanistically.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural model of PAF1 engaging paused vs. elongating Pol II","Determinants partitioning PAF1 between PAF1C and PHF5A-DDX3 sub-complexes unknown","How environmental/promoter signals set Paf1 occupancy is undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[10,13,19,21]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[8,17]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[5,21,22,23]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[8,17]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,4,6]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[2,4]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[2,11,19]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,10,13,21]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[4,7,11,17,23]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[5,22,24]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,16]}],"complexes":["PAF1 complex (PAF1C)","PAF1-PHF5A-DDX3 sub-complex"],"partners":["CTR9","LEO1","CDC73","RTF1","CFT1","OCT4","RAD6","PHF5A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P28328","full_name":"Peroxisome biogenesis factor 2","aliases":["35 kDa peroxisomal membrane protein","Peroxin-2","Peroxisomal membrane protein 3","Peroxisome assembly factor 1","PAF-1","RING finger protein 72"],"length_aa":305,"mass_kda":34.8,"function":"E3 ubiquitin-protein ligase component of a retrotranslocation channel required for peroxisome organization by mediating export of the PEX5 receptor from peroxisomes to the cytosol, thereby promoting PEX5 recycling (PubMed:24662292). The retrotranslocation channel is composed of PEX2, PEX10 and PEX12; each subunit contributing transmembrane segments that coassemble into an open channel that specifically allows the passage of PEX5 through the peroxisomal membrane (By similarity). PEX2 also regulates peroxisome organization by acting as a E3 ubiquitin-protein ligase (By similarity). PEX2 ubiquitinates PEX5 during its passage through the retrotranslocation channel: catalyzes monoubiquitination of PEX5 at 'Cys-11', a modification that acts as a signal for PEX5 extraction into the cytosol (By similarity). Required for pexophagy in response to starvation by mediating ubiquitination of peroxisomal proteins, such as PEX5 and ABCD3/PMP70 (PubMed:27597759). Also involved in the response to reactive oxygen species (ROS) by mediating 'Lys-48'-linked polyubiquitination and subsequent degradation of PNPLA2/ATGL, thereby regulating lipolysis (PubMed:34903883)","subcellular_location":"Peroxisome membrane","url":"https://www.uniprot.org/uniprotkb/P28328/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/PAF1","classification":"Common Essential","n_dependent_lines":1134,"n_total_lines":1208,"dependency_fraction":0.9387417218543046},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"SSRP1","stoichiometry":4.0},{"gene":"TOP1","stoichiometry":4.0},{"gene":"CPSF6","stoichiometry":0.2},{"gene":"CSNK2B","stoichiometry":0.2},{"gene":"HIST2H2BE","stoichiometry":0.2},{"gene":"POLR2F","stoichiometry":0.2},{"gene":"SNRPA","stoichiometry":0.2},{"gene":"SNRPB","stoichiometry":0.2},{"gene":"SNRPC","stoichiometry":0.2},{"gene":"SNRPF","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PAF1","total_profiled":1310},"omim":[{"mim_id":"619818","title":"ELONGATION FACTOR 1; ELOF1","url":"https://www.omim.org/entry/619818"},{"mim_id":"615514","title":"CYCLIN-DEPENDENT KINASE 12; CDK12","url":"https://www.omim.org/entry/615514"},{"mim_id":"611633","title":"RTF1 HOMOLOG, PAF1/RNA POLYMERASE II COMPLEX COMPONENT; RTF1","url":"https://www.omim.org/entry/611633"},{"mim_id":"610507","title":"LEO1 HOMOLOG, PAF1/RNA POLYMERASE II COMPLEX COMPONENT; LEO1","url":"https://www.omim.org/entry/610507"},{"mim_id":"610506","title":"PAF1 HOMOLOG, PAF1/RNA POLYMERASE II COMPLEX COMPONENT; PAF1","url":"https://www.omim.org/entry/610506"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli fibrillar center","reliability":"Additional"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PAF1"},"hgnc":{"alias_symbol":["PD2","F23149_1","FLJ11123"],"prev_symbol":[]},"alphafold":{"accession":"P28328","domains":[{"cath_id":"-","chopping":"2-183","consensus_level":"high","plddt":86.0515,"start":2,"end":183},{"cath_id":"3.30.40.10","chopping":"241-296","consensus_level":"medium","plddt":80.3534,"start":241,"end":296}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P28328","model_url":"https://alphafold.ebi.ac.uk/files/AF-P28328-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P28328-F1-predicted_aligned_error_v6.png","plddt_mean":80.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PAF1","jax_strain_url":"https://www.jax.org/strain/search?query=PAF1"},"sequence":{"accession":"P28328","fasta_url":"https://rest.uniprot.org/uniprotkb/P28328.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P28328/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P28328"}},"corpus_meta":[{"pmid":"24008419","id":"PMC_24008419","title":"Infernal 1.1: 100-fold faster RNA homology searches.","date":"2013","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24008419","citation_count":2652,"is_preprint":false},{"pmid":"20086235","id":"PMC_20086235","title":"Interleukin-1 (IL-1) pathway.","date":"2010","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/20086235","citation_count":778,"is_preprint":false},{"pmid":"9646173","id":"PMC_9646173","title":"Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.","date":"1998","source":"International reviews of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9646173","citation_count":531,"is_preprint":false},{"pmid":"22815045","id":"PMC_22815045","title":"Atrogin-1, MuRF-1, and sarcopenia.","date":"2012","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/22815045","citation_count":301,"is_preprint":false},{"pmid":"11023493","id":"PMC_11023493","title":"PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11023493","citation_count":294,"is_preprint":false},{"pmid":"9819428","id":"PMC_9819428","title":"Delta-1 activation of notch-1 signaling results in HES-1 transactivation.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9819428","citation_count":283,"is_preprint":false},{"pmid":"10753833","id":"PMC_10753833","title":"GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10753833","citation_count":279,"is_preprint":false},{"pmid":"11927560","id":"PMC_11927560","title":"The Paf1 complex physically and functionally associates with transcription elongation factors in vivo.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11927560","citation_count":267,"is_preprint":false},{"pmid":"15279787","id":"PMC_15279787","title":"Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex.","date":"2004","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/15279787","citation_count":257,"is_preprint":false},{"pmid":"15313461","id":"PMC_15313461","title":"Transferrin receptor 1.","date":"2004","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15313461","citation_count":245,"is_preprint":false},{"pmid":"20421639","id":"PMC_20421639","title":"(1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20421639","citation_count":224,"is_preprint":false},{"pmid":"20060942","id":"PMC_20060942","title":"The Paf1 complex: platform or player in RNA polymerase II transcription?","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20060942","citation_count":213,"is_preprint":false},{"pmid":"11884586","id":"PMC_11884586","title":"Ctr9, Rtf1, and Leo1 are components of the Paf1/RNA polymerase II complex.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11884586","citation_count":206,"is_preprint":false},{"pmid":"26279188","id":"PMC_26279188","title":"PAF1, a Molecular Regulator of Promoter-Proximal Pausing by RNA Polymerase II.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26279188","citation_count":197,"is_preprint":false},{"pmid":"9785472","id":"PMC_9785472","title":"Interleukin-1.","date":"1998","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9785472","citation_count":176,"is_preprint":false},{"pmid":"20204399","id":"PMC_20204399","title":"CaV2.1 channelopathies.","date":"2010","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20204399","citation_count":175,"is_preprint":false},{"pmid":"15923622","id":"PMC_15923622","title":"The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15923622","citation_count":154,"is_preprint":false},{"pmid":"19804759","id":"PMC_19804759","title":"CDE-1 affects chromosome segregation through uridylation of CSR-1-bound siRNAs.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19804759","citation_count":149,"is_preprint":false},{"pmid":"15149594","id":"PMC_15149594","title":"The Paf1 complex has functions independent of actively transcribing RNA polymerase II.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15149594","citation_count":149,"is_preprint":false},{"pmid":"19037882","id":"PMC_19037882","title":"Thyroid transcription factor-1 (TTF-1/Nkx2.1/TITF1) gene regulation in the lung.","date":"2009","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/19037882","citation_count":145,"is_preprint":false},{"pmid":"15057910","id":"PMC_15057910","title":"Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration.","date":"2004","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15057910","citation_count":141,"is_preprint":false},{"pmid":"9474745","id":"PMC_9474745","title":"Role of PU.1 in hematopoiesis.","date":"1998","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/9474745","citation_count":136,"is_preprint":false},{"pmid":"28870425","id":"PMC_28870425","title":"Emerging Insights into the Roles of the Paf1 Complex in Gene Regulation.","date":"2017","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28870425","citation_count":130,"is_preprint":false},{"pmid":"25231297","id":"PMC_25231297","title":"HIV-1 uncoating is facilitated by dynein and kinesin 1.","date":"2014","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/25231297","citation_count":115,"is_preprint":false},{"pmid":"16354696","id":"PMC_16354696","title":"Drosophila Paf1 modulates chromatin structure at actively transcribed genes.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16354696","citation_count":108,"is_preprint":false},{"pmid":"11738790","id":"PMC_11738790","title":"Phenotypic spectrum of mutations in DAX-1 and SF-1.","date":"2001","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11738790","citation_count":105,"is_preprint":false},{"pmid":"28860207","id":"PMC_28860207","title":"PAF1 regulation of promoter-proximal pause release via enhancer activation.","date":"2017","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28860207","citation_count":101,"is_preprint":false},{"pmid":"25306110","id":"PMC_25306110","title":"MacroH2A1.1 and PARP-1 cooperate to regulate transcription by promoting CBP-mediated H2B acetylation.","date":"2014","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25306110","citation_count":98,"is_preprint":false},{"pmid":"18174212","id":"PMC_18174212","title":"Kv7.1 (KCNQ1) properties and channelopathies.","date":"2008","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18174212","citation_count":96,"is_preprint":false},{"pmid":"25628647","id":"PMC_25628647","title":"Regulation of IGF -1 signaling by microRNAs.","date":"2015","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25628647","citation_count":95,"is_preprint":false},{"pmid":"25807481","id":"PMC_25807481","title":"The Paf1 complex represses small-RNA-mediated epigenetic gene silencing.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/25807481","citation_count":85,"is_preprint":false},{"pmid":"12432832","id":"PMC_12432832","title":"Neurofibromatosis 1.","date":"2002","source":"Neurologic clinics","url":"https://pubmed.ncbi.nlm.nih.gov/12432832","citation_count":84,"is_preprint":false},{"pmid":"33811920","id":"PMC_33811920","title":"The Paf1 Complex: A Keystone of Nuclear Regulation Operating at the Interface of Transcription and Chromatin.","date":"2021","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/33811920","citation_count":83,"is_preprint":false},{"pmid":"26048278","id":"PMC_26048278","title":"Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60.","date":"2015","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/26048278","citation_count":83,"is_preprint":false},{"pmid":"24837678","id":"PMC_24837678","title":"H2B ubiquitylation promotes RNA Pol II processivity via PAF1 and pTEFb.","date":"2014","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/24837678","citation_count":82,"is_preprint":false},{"pmid":"19074142","id":"PMC_19074142","title":"Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19074142","citation_count":81,"is_preprint":false},{"pmid":"23018752","id":"PMC_23018752","title":"1q21.1 Microduplication expression in adults.","date":"2012","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23018752","citation_count":79,"is_preprint":false},{"pmid":"29864419","id":"PMC_29864419","title":"Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1.","date":"2018","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/29864419","citation_count":78,"is_preprint":false},{"pmid":"25099282","id":"PMC_25099282","title":"Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25099282","citation_count":76,"is_preprint":false},{"pmid":"18469135","id":"PMC_18469135","title":"Direct interactions between the Paf1 complex and a cleavage and polyadenylation factor are revealed by dissociation of Paf1 from RNA polymerase II.","date":"2008","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/18469135","citation_count":76,"is_preprint":false},{"pmid":"12411705","id":"PMC_12411705","title":"Microbial dehalorespiration with 1,1,1-trichloroethane.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12411705","citation_count":75,"is_preprint":false},{"pmid":"28794034","id":"PMC_28794034","title":"An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1.","date":"2017","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/28794034","citation_count":74,"is_preprint":false},{"pmid":"9987673","id":"PMC_9987673","title":"Thrombospondin-1, PECAM-1, and regulation of angiogenesis.","date":"1999","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/9987673","citation_count":73,"is_preprint":false},{"pmid":"11483518","id":"PMC_11483518","title":"Regulation of BOB.1/OBF.1 stability by SIAH.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11483518","citation_count":72,"is_preprint":false},{"pmid":"11853016","id":"PMC_11853016","title":"Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain.","date":"2002","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11853016","citation_count":71,"is_preprint":false},{"pmid":"36696089","id":"PMC_36696089","title":"Rapid Access to 2-Substituted Bicyclo[1.1.1]pentanes.","date":"2023","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/36696089","citation_count":68,"is_preprint":false},{"pmid":"26518661","id":"PMC_26518661","title":"The Paf1 complex factors Leo1 and Paf1 promote local histone turnover to modulate chromatin states in fission yeast.","date":"2015","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/26518661","citation_count":68,"is_preprint":false},{"pmid":"31110321","id":"PMC_31110321","title":"Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD.","date":"2019","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31110321","citation_count":65,"is_preprint":false},{"pmid":"32781084","id":"PMC_32781084","title":"RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.","date":"2020","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/32781084","citation_count":59,"is_preprint":false},{"pmid":"24029427","id":"PMC_24029427","title":"Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes.","date":"2013","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/24029427","citation_count":57,"is_preprint":false},{"pmid":"24038468","id":"PMC_24038468","title":"Structural insights into Paf1 complex assembly and histone binding.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24038468","citation_count":56,"is_preprint":false},{"pmid":"30213788","id":"PMC_30213788","title":"Nedd4-Binding Protein 1 and TNFAIP3-Interacting Protein 1 Control MHC-1 Display in Neuroblastoma.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30213788","citation_count":54,"is_preprint":false},{"pmid":"10713349","id":"PMC_10713349","title":"PU.1 expression in microglia.","date":"2000","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/10713349","citation_count":52,"is_preprint":false},{"pmid":"33951726","id":"PMC_33951726","title":"Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients.","date":"2021","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33951726","citation_count":51,"is_preprint":false},{"pmid":"10597240","id":"PMC_10597240","title":"Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10597240","citation_count":51,"is_preprint":false},{"pmid":"12489180","id":"PMC_12489180","title":"TGF beta-1 downregulates DMP-1 and DSPP in odontoblasts.","date":"2002","source":"Connective tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/12489180","citation_count":50,"is_preprint":false},{"pmid":"18324520","id":"PMC_18324520","title":"APE1/Ref-1 regulates PTEN expression mediated by Egr-1.","date":"2008","source":"Free radical research","url":"https://pubmed.ncbi.nlm.nih.gov/18324520","citation_count":50,"is_preprint":false},{"pmid":"15371551","id":"PMC_15371551","title":"Predicting genes expressed via -1 and +1 frameshifts.","date":"2004","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15371551","citation_count":50,"is_preprint":false},{"pmid":"28190769","id":"PMC_28190769","title":"Paf1 Has Distinct Roles in Transcription Elongation and Differential Transcript Fate.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28190769","citation_count":49,"is_preprint":false},{"pmid":"18056379","id":"PMC_18056379","title":"Interactions between Idd5.1/Ctla4 and other type 1 diabetes genes.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18056379","citation_count":49,"is_preprint":false},{"pmid":"32222817","id":"PMC_32222817","title":"Skeletal muscle CaV1.1 channelopathies.","date":"2020","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32222817","citation_count":48,"is_preprint":false},{"pmid":"35624087","id":"PMC_35624087","title":"PI(18:1/18:1) is a SCD1-derived lipokine that limits stress signaling.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35624087","citation_count":48,"is_preprint":false},{"pmid":"35363521","id":"PMC_35363521","title":"Coordinated regulation of RNA polymerase II pausing and elongation progression by PAF1.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35363521","citation_count":47,"is_preprint":false},{"pmid":"19821493","id":"PMC_19821493","title":"RNA polymerase II associated factor 1/PD2 maintains self-renewal by its interaction with Oct3/4 in mouse embryonic stem cells.","date":"2009","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/19821493","citation_count":47,"is_preprint":false},{"pmid":"11406616","id":"PMC_11406616","title":"p21Cip-1/SDI-1/WAF-1 gene is involved in chondrogenic differentiation of ATDC5 cells in vitro.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11406616","citation_count":44,"is_preprint":false},{"pmid":"31092016","id":"PMC_31092016","title":"Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial Hypertension.","date":"2019","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31092016","citation_count":42,"is_preprint":false},{"pmid":"21338598","id":"PMC_21338598","title":"The PAF1 complex differentially regulates cardiomyocyte specification.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21338598","citation_count":42,"is_preprint":false},{"pmid":"18814180","id":"PMC_18814180","title":"Elk-1, CREB, and MKP-1 regulate Egr-1 expression in gonadotropin-releasing hormone stimulated gonadotrophs.","date":"2008","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18814180","citation_count":41,"is_preprint":false},{"pmid":"10412368","id":"PMC_10412368","title":"DAX-1, an 'antitestis' gene.","date":"1999","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/10412368","citation_count":39,"is_preprint":false},{"pmid":"35759692","id":"PMC_35759692","title":"On-DNA Hydroalkylation to Introduce Diverse Bicyclo[1.1.1]pentanes and Abundant Alkyls via Halogen Atom Transfer.","date":"2022","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/35759692","citation_count":39,"is_preprint":false},{"pmid":"24394957","id":"PMC_24394957","title":"miRNA-1 regulates endothelin-1 in diabetes.","date":"2014","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24394957","citation_count":39,"is_preprint":false},{"pmid":"30228257","id":"PMC_30228257","title":"Paf1 and Ctr9 subcomplex formation is essential for Paf1 complex assembly and functional regulation.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30228257","citation_count":38,"is_preprint":false},{"pmid":"31291500","id":"PMC_31291500","title":"Reactions of 2-Aryl-1,3-Dithianes and [1.1.1]Propellane.","date":"2019","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/31291500","citation_count":38,"is_preprint":false},{"pmid":"8579881","id":"PMC_8579881","title":"An overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane).","date":"1995","source":"Human & experimental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/8579881","citation_count":37,"is_preprint":false},{"pmid":"10744748","id":"PMC_10744748","title":"Gab-1-mediated IGF-1 signaling in IRS-1-deficient 3T3 fibroblasts.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10744748","citation_count":36,"is_preprint":false},{"pmid":"29311159","id":"PMC_29311159","title":"PD2/PAF1 at the Crossroads of the Cancer Network.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29311159","citation_count":35,"is_preprint":false},{"pmid":"19265","id":"PMC_19265","title":"pD2-, pA2- and pD2'-values of a series of compounds in a histaminic and a cholinergic system.","date":"1977","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19265","citation_count":35,"is_preprint":false},{"pmid":"22500837","id":"PMC_22500837","title":"The 1-1-1 fallacy.","date":"2012","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/22500837","citation_count":32,"is_preprint":false},{"pmid":"40136024","id":"PMC_40136024","title":"Neutralization and spike stability of JN.1-derived LB.1, KP.2.3, KP.3, and KP.3.1.1 subvariants.","date":"2025","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/40136024","citation_count":30,"is_preprint":false},{"pmid":"35294889","id":"PMC_35294889","title":"The PAF1 complex promotes 3' processing of pervasive transcripts.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35294889","citation_count":29,"is_preprint":false},{"pmid":"31525119","id":"PMC_31525119","title":"The Paf1 complex transcriptionally regulates the mitochondrial-anchored protein Atg32 leading to activation of mitophagy.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/31525119","citation_count":29,"is_preprint":false},{"pmid":"30444039","id":"PMC_30444039","title":"Translocation and activation of sphingosine kinase 1 by ceramide-1-phosphate.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30444039","citation_count":28,"is_preprint":false},{"pmid":"21695196","id":"PMC_21695196","title":"Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21695196","citation_count":28,"is_preprint":false},{"pmid":"24276247","id":"PMC_24276247","title":"Enhanced expression of transferrin receptor 1 contributes to oncogenic signalling by sphingosine kinase 1.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/24276247","citation_count":28,"is_preprint":false},{"pmid":"34797876","id":"PMC_34797876","title":"Nuclear dengue virus NS5 antagonizes expression of PAF1-dependent immune response genes.","date":"2021","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/34797876","citation_count":27,"is_preprint":false},{"pmid":"8804025","id":"PMC_8804025","title":"Molecular analysis of the lissencephaly gene 1 (LIS-1) in medulloblastomas.","date":"1996","source":"Neuropathology and applied neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/8804025","citation_count":27,"is_preprint":false},{"pmid":"24947474","id":"PMC_24947474","title":"PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24947474","citation_count":26,"is_preprint":false},{"pmid":"22046413","id":"PMC_22046413","title":"Human RNA polymerase II-association factor 1 (hPaf1/PD2) regulates histone methylation and chromatin remodeling in pancreatic cancer.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22046413","citation_count":26,"is_preprint":false},{"pmid":"21978893","id":"PMC_21978893","title":"9-1-1: PCNA's specialized cousin.","date":"2011","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21978893","citation_count":25,"is_preprint":false},{"pmid":"29363163","id":"PMC_29363163","title":"LncRNA-RP11-714G18.1 suppresses vascular cell migration via directly targeting LRP2BP.","date":"2017","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/29363163","citation_count":25,"is_preprint":false},{"pmid":"39282390","id":"PMC_39282390","title":"Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39282390","citation_count":24,"is_preprint":false},{"pmid":"37216505","id":"PMC_37216505","title":"Paf1 complex subunit Rtf1 stimulates H2B ubiquitylation by interacting with the highly conserved N-terminal helix of Rad6.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37216505","citation_count":24,"is_preprint":false},{"pmid":"19825991","id":"PMC_19825991","title":"PU.1 activation relieves GATA-1-mediated repression of Cebpa and Cbfb during leukemia differentiation.","date":"2009","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/19825991","citation_count":24,"is_preprint":false},{"pmid":"23109428","id":"PMC_23109428","title":"Effects of the Paf1 complex and histone modifications on snoRNA 3'-end formation reveal broad and locus-specific regulation.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23109428","citation_count":24,"is_preprint":false},{"pmid":"25845046","id":"PMC_25845046","title":"PDX-1 (pancreatic/duodenal homeobox-1 protein 1).","date":"2014","source":"Pathologica","url":"https://pubmed.ncbi.nlm.nih.gov/25845046","citation_count":23,"is_preprint":false},{"pmid":"28708824","id":"PMC_28708824","title":"Tex19.1 promotes Spo11-dependent meiotic recombination in mouse spermatocytes.","date":"2017","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28708824","citation_count":23,"is_preprint":false},{"pmid":"29016962","id":"PMC_29016962","title":"An Apple Protein Kinase MdSnRK1.1 Interacts with MdCAIP1 to Regulate ABA Sensitivity.","date":"2017","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29016962","citation_count":22,"is_preprint":false},{"pmid":"28844648","id":"PMC_28844648","title":"Drosophila PAF1 Modulates PIWI/piRNA Silencing Capacity.","date":"2017","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/28844648","citation_count":21,"is_preprint":false},{"pmid":"34038245","id":"PMC_34038245","title":"Maresin-1 induces cardiomyocyte hypertrophy through IGF-1 paracrine pathway.","date":"2021","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34038245","citation_count":20,"is_preprint":false},{"pmid":"26689992","id":"PMC_26689992","title":"Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26689992","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48408,"output_tokens":6835,"usd":0.123874,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15827,"output_tokens":6221,"usd":0.11733,"stage2_stop_reason":"end_turn"},"total_usd":0.241204,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"PAF1 (Paf1) and Leo1 are components of the RNA polymerase II-associated Paf1 complex, which physically interacts with transcription elongation factors Spt4-Spt5 and Spt16-Pob3 (yeast FACT). Genetic and physical interactions were demonstrated, and loss of Paf1 complex function causes 6-azauracil sensitivity and diminished PUR5 induction, consistent with impaired transcription elongation.\",\n      \"method\": \"Affinity purification, mass spectrometry, Co-IP, genetic suppressor screen, 6-azauracil sensitivity assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP and genetic epistasis, replicated across multiple approaches in same study, foundational complex characterization\",\n      \"pmids\": [\"11927560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Ctr9, Rtf1, and Leo1 are components of the yeast Paf1 complex associated with Pol II but not Srb-mediator. Deletion of PAF1 or CTR9 causes severe pleiotropic phenotypes; deletion of LEO1 or RTF1 suppresses many paf1Δ phenotypes (e.g., restoring CLN1 expression), indicating Paf1 complex integrity is required for normal transcription.\",\n      \"method\": \"Tandem affinity purification, mass spectrometry, genetic double-mutant analysis, gene expression assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — TAP-MS complex identification plus genetic epistasis in multiple double mutants, orthogonal methods\",\n      \"pmids\": [\"11884586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The yeast Paf1 complex (Paf1, Ctr9, Cdc73, Rtf1, Leo1) travels with Pol II on chromatin at promoters and coding regions of active genes. Loss of Paf1 reduces Pol II Ser2 phosphorylation and shortens poly(A) tails. Loss of Rtf1 or Cdc73 dissociates the Paf1 complex from Pol II and chromatin, yet remaining complex members stay stably associated with each other. The major functions of Paf1 can therefore operate independently of actively transcribing Pol II.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), functional tagging, poly(A) tail analysis, fractionation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-based localization with functional consequence (Ser2 phosphorylation, poly(A) tails) plus multiple genetic backgrounds, multiple orthogonal methods\",\n      \"pmids\": [\"15149594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Human PAF1 physically interacts with the tumor suppressor parafibromin (HRPT2 product) and with LEO1 and CTR9, forming a complex that also associates with Ser5- and Ser2-phosphorylated forms of the RNA Pol II large subunit CTD. This interaction depends on a C-terminal domain of parafibromin deleted in ~80% of clinically relevant mutations.\",\n      \"method\": \"Co-immunoprecipitation, RNAi knockdown, co-localization\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with multiple PAF1C subunits, domain-deletion mapping, functional cell-cycle readout\",\n      \"pmids\": [\"15923622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Drosophila Paf1 colocalizes with phosphorylated (actively transcribing) Pol II on polytene chromosomes and is recruited to activated heat shock genes. RNAi depletion of Paf1 impairs Hsp70 RNA induction, reduces trimethylation of histone H3K4 at the Hsp70 promoter, and significantly decreases recruitment of chromatin factors Spt6 and FACT, revealing a role for Paf1 in modulating chromatin structure during active transcription.\",\n      \"method\": \"RNAi, chromatin immunoprecipitation (ChIP), immunofluorescence on polytene chromosomes, RNA assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — RNAi loss-of-function with multiple phenotypic readouts (RNA levels, histone marks, factor recruitment) plus ChIP, replicated in metazoan model\",\n      \"pmids\": [\"16354696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The Paf1 complex directly interacts with the cleavage and polyadenylation factor Cft1. This interaction normally requires the Pol II-associated form of Paf1C; when Paf1C is dissociated from Pol II (by loss of Rtf1 or Cdc73), a direct Cft1–Paf1C interaction becomes detectable. Loss of Paf1, Ctr9, Cdc73, or Rtf1 reduces Pol II Ser2 phosphorylation and increases read-through of a polyadenylation site, supporting a role for Paf1C in recruiting 3'-end processing factors.\",\n      \"method\": \"Co-immunoprecipitation, functional tagging, polyadenylation read-through assay, Pol II CTD phosphorylation assay\",\n      \"journal\": \"Eukaryotic cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying direct Cft1–Paf1C interaction, coupled with functional 3'-end processing readouts, multiple subunit deletions tested\",\n      \"pmids\": [\"18469135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PAF1/PD2 (the human homolog of Paf1) is overexpressed in mouse embryonic stem cells (ESCs), interacts physically with Oct3/4 and RNA Pol II, and is required for maintenance of ESC self-renewal. Knockdown or knockout of PAF1 reduces Oct3/4, SOX2, Nanog, and Shh levels, increases apoptosis, decreases S-phase fraction, and promotes endodermal differentiation markers.\",\n      \"method\": \"Co-immunoprecipitation, siRNA/shRNA knockdown, knockout ESCs, flow cytometry, gene expression analysis\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for Oct3/4 interaction, KO/KD with defined cellular phenotypes, single lab\",\n      \"pmids\": [\"19821493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PAF1 (hPaf1/PD2) knockdown in pancreatic cancer cells reduces di- and tri-methylation of histone H3K4. PAF1 colocalizes with the H3K4 methyltransferase MLL1; reduction of PAF1 decreases MLL1 expression and reduces nuclear localization of the chromatin remodeling enzyme CHD1 (which reads H3K4me2/3 marks). PAF1 physically interacts with CHD1, and ectopic PAF1 expression rescues CHD1 nuclear localization, demonstrating PAF1 regulation of chromatin remodeling via H3K4 methylation.\",\n      \"method\": \"siRNA knockdown, Co-immunoprecipitation, confocal co-localization, micrococcal nuclease digestion, Western blot\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for PAF1-CHD1 interaction, KD with histone modification and chromatin structure readouts, rescue experiment, single lab\",\n      \"pmids\": [\"22046413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The crystal structure of the human PAF1/LEO1 subcomplex reveals a tightly associated heterodimer formed through antiparallel beta-sheet interactions. LEO1 associates with the PAF1 complex through PAF1, and CTR9 is the key scaffold protein for overall PAF1C assembly. The PAF1/LEO1 heterodimer binds histone H3, the histone octamer, and the nucleosome in vitro.\",\n      \"method\": \"X-ray crystallography, biochemical binding assays (pull-down with histones/nucleosomes), deletion analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure plus in vitro reconstitution of histone binding, multiple orthogonal biochemical experiments in single study\",\n      \"pmids\": [\"24038468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"H2B K34 ubiquitylation by the MOF-MSL complex acts in early transcription elongation. PAF1, MSL, and RNF20/40 complexes are recruited and stabilized at active gene promoters through direct binary interactions. These complexes regulate chromatin association of pTEFb through a positive feedback loop, facilitating Pol II transition during early elongation.\",\n      \"method\": \"Co-immunoprecipitation (binary interactions), ChIP-seq, siRNA knockdown, RNA Pol II processivity assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for direct binary interactions, genome-wide ChIP-seq, functional elongation readouts, single lab\",\n      \"pmids\": [\"24837678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PAF1 possesses an evolutionarily conserved function in metazoans in regulating RNA Pol II promoter-proximal pausing. Reduction in PAF1 levels leads to increased release of paused Pol II into gene bodies at thousands of genes, increased nascent and mature transcripts, and increased Pol II CTD Ser2 phosphorylation. This is mechanistically explained by increased recruitment of the Ser2-kinase super elongation complex (SEC) upon PAF1 depletion.\",\n      \"method\": \"siRNA depletion, GRO-seq (global run-on sequencing), ChIP-seq, RNA-seq\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide nascent transcription and ChIP-seq in human cells, mechanistic link to SEC/Ser2P, multiple orthogonal methods, high-impact journal\",\n      \"pmids\": [\"26279188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The Paf1 complex (Paf1C) in fission yeast prevents RNAi-directed heterochromatin formation by promoting efficient transcription termination and rapid release of nascent RNA from the site of transcription. In Paf1C mutants, synthetic hairpin RNA can trigger stable, heritable heterochromatin at homologous loci through secondary siRNA production. Compromised transcription termination is sufficient to initiate bistable heterochromatin, but impairment of both termination and nascent transcript release is required for stability.\",\n      \"method\": \"Genetic screen, heterochromatin reporter assays, RNA-seq, ChIP, epistasis analysis in fission yeast\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic and biochemical approaches, mechanistic model with defined epistatic relationships, high-impact journal\",\n      \"pmids\": [\"25807481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Leo1 and Paf1 (subcomplex of PAF1C) are required to prevent spreading of heterochromatin into euchromatin in fission yeast. Loss of Leo1 decreases nucleosome turnover, leading to heterochromatin stabilization at facultative heterochromatin loci, in an RNAi-independent manner.\",\n      \"method\": \"Random mutagenesis screen, ChIP-exo (genome-wide H3K9me2 mapping), histone turnover assay\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-exo and histone turnover assays with genetic KO, single lab, mechanistic link to chromatin state maintenance\",\n      \"pmids\": [\"26518661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PAF1 occupies transcriptional enhancers and restrains hyperactivation of a subset of them. PAF1 loss leads to enhancer activation, which in turn releases Pol II from paused promoters of nearby PAF1 target genes. Knockout of PAF1-regulated enhancers attenuates release of paused Pol II from cognate promoters without major effects on pausing establishment.\",\n      \"method\": \"ChIP-seq, CRISPR enhancer knockout, GRO-seq, nascent RNA assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR enhancer KO combined with ChIP-seq and GRO-seq, multiple orthogonal approaches establishing enhancer-PAF1-pausing mechanistic axis\",\n      \"pmids\": [\"28860207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Paf1 level on Pol II varies between genes, is dynamically controlled via promoters by environmental factors, and correlates with levels of transcript processing and export factors on the encoded RNA. High Paf1 levels on Pol II promote nuclear export of transcripts, while low levels correlate with nuclear retention. Loss of Paf1 causes marked transcription elongation defects, but low levels are sufficient for elongation.\",\n      \"method\": \"Native elongating transcript sequencing (NET-seq), strand-specific nucleotide-resolution RNA analysis, yeast genetics\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — nucleotide-resolution elongation assay, multiple mutant strains, mechanistic distinction between elongation and transcript fate functions\",\n      \"pmids\": [\"28190769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Drosophila PAF1 antagonizes PIWI/piRNA-directed gene silencing. PAF1 knockdown enhances PIWI silencing of reporters when piRNAs target transcript regions proximal to the promoter. Loss of PAF1 suppresses endogenous transposable element transcript maturation, suggesting PAF1 acts mechanistically downstream of initial PIWI silencing events in a manner conserved with fission yeast Paf1C opposing AGO1/siRNA silencing.\",\n      \"method\": \"RNAi in Drosophila OSS cells, piRNA-targeted reporter assay, transposable element expression analysis\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — RNAi with defined reporter readout and TE expression, single lab, single model system\",\n      \"pmids\": [\"28844648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PAF1 interacts with PHF5A and DDX3 in pancreatic cancer stem cells (CSCs), independently of its role as a PAF1 complex (PAF1C) component. The PAF1-PHF5A-DDX3 sub-complex binds to the promoter of Nanog and regulates stemness gene expression. Knockdown of PAF1 reduces CSC markers (NANOG, SOX9, β-CATENIN, CD44v6, ALDH1), tumor sphere formation, and orthotopic tumor growth. DDX3 inhibitor RK-33 reduces PAF1-DDX3-Nanog promoter binding and CSC self-renewal.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, ChIP-seq, CRISPR/Cas9 KO, shRNA KD, orthotopic tumor model, flow cytometry\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP/MS for interaction, ChIP-seq for promoter binding, KO/KD with functional readouts, single lab\",\n      \"pmids\": [\"32781084\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structures of both human and yeast Ctr9/Paf1 subcomplexes reveal heterodimers with similar conformations, with an interface between the tetratricopeptide repeat (TPR) module of Ctr9 and Paf1. Formation of the Ctr9/Paf1 heterodimer is required for Paf1C assembly and yeast viability. Disruption of the Ctr9-Paf1 interaction greatly reduces histone H3 methylation in vivo.\",\n      \"method\": \"X-ray crystallography (human and yeast), biochemical assembly assays, yeast viability assays, histone modification analysis in vivo\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures for two species, biochemical reconstitution, viability and histone modification functional validation in multiple organisms\",\n      \"pmids\": [\"30228257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PAF1C (specifically Paf1 and Leo1 subunits) selectively promotes transcription of long, toxic GGGGCC repeat expansions (≥30 repeats) in C9orf72-associated FTD/ALS but not shorter, nontoxic repeats in Drosophila. PAF1C depletion reduces both repeat RNA and GR dipeptide production. LEO1 binds C9+ repeat chromatin in human C9+ FTD cells, and PAF1C is upregulated following long repeat expression.\",\n      \"method\": \"Drosophila genetic screen (unbiased), RNA quantification, ChIP (LEO1 binding to C9+ chromatin), transgenic models\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — unbiased genetic screen plus ChIP validation in human cells, multiple organisms, single lab\",\n      \"pmids\": [\"31110321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The Paf1 complex (Paf1C) acts as a transcriptional repressor of ATG32 in yeast, suppressing mitophagy under glucose-rich conditions. Deletion of PAF1 or CTR9 increases ATG32 and ATG11 expression and facilitates mitophagy. Paf1C binds the ATG32 promoter; glucose starvation triggers dissociation of Paf1C from ATG32, de-repressing it. This mitophagic role is independent of Paf1C's positive regulatory functions and is conserved in mammals.\",\n      \"method\": \"ChIP (Paf1C binding to ATG32 promoter), gene deletion, RT-qPCR, mitophagy assays, mammalian validation\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct promoter binding, genetic KO with functional mitophagy readout, mammalian conservation shown, single lab\",\n      \"pmids\": [\"31525119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Dengue virus NS5 physically interacts with PAF1C (requiring NS5 nuclear localization and the C-terminal region of its methyltransferase domain) and antagonizes PAF1C recruitment to immune response genes. PAF1 knockout enhances DENV2 virion production. PAF1 is required for expression of STAT2-independent immune response genes, defining a distinct antiviral pathway.\",\n      \"method\": \"Co-immunoprecipitation, NS5 mutant analysis, PAF1 CRISPR KO, RNA-seq, viral titer assay\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain mapping, KO with viral replication and transcriptome readouts, single lab\",\n      \"pmids\": [\"34797876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PAF1 governs Pol II promoter-proximal pausing partially by recruiting Integrator-PP2A (INTAC) complex. Acute PAF1 degradation (using rapid degron system) causes most destabilized Pol II to undergo effective release, resulting from skewed balance between INTAC and P-TEFb and leading to hyperphosphorylated SPT5. PAF1 also ensures productive elongation progression. PAF1 degradation causes cumulative decline in histone modifications, further influencing transcriptional output.\",\n      \"method\": \"Rapid degron system (acute degradation), ChIP-seq, GRO-seq, mass spectrometry, phospho-proteomics\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — acute degradation system (avoids adaptation), genome-wide ChIP-seq and GRO-seq, phospho-proteomics, multiple orthogonal approaches\",\n      \"pmids\": [\"35363521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PAF1C promotes 3' processing (cleavage and termination) of pervasive transcripts (eRNAs and PROMPTs) by facilitating Integrator complex recruitment to sites of pervasive transcript cleavage 1-3 kb downstream of TSSs. PAF1C also recruits Integrator to coding genes but dissociates from Integrator upon entry into processive elongation.\",\n      \"method\": \"PAF1C depletion (siRNA/degradation), PRO-seq, ChIP-seq, co-immunoprecipitation\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for PAF1C-Integrator interaction, depletion with functional cleavage and termination readouts, single lab\",\n      \"pmids\": [\"35294889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The Rtf1 subunit of Paf1C directly interacts with the highly conserved N-terminal helix of the ubiquitin conjugase Rad6 through Rtf1's histone modification domain (HMD). This interaction stimulates H2B K123 ubiquitylation (H2BK123ub) in vivo and in vitro. Separation-of-function RAD6 mutations that impair the Rad6-HMD interface greatly reduce H2BK123ub but not other Rad6 functions, and yield transcriptome profiles matching an H2B ubiquitylation site mutant.\",\n      \"method\": \"In vitro cross-linking/mass spectrometry (interaction mapping), in vitro ubiquitylation assay, yeast genetics (separation-of-function mutants), RNA-seq, in vivo protein cross-linking\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of ubiquitylation, cross-linking MS for contact mapping, multiple separation-of-function alleles, transcriptome validation, multiple orthogonal methods\",\n      \"pmids\": [\"37216505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Paf1C in Saccharomyces cerevisiae is broadly required for snoRNA 3'-end formation, functioning with RNA-binding proteins Nrd1 and Nab3. Regulation is locus-specific: different Paf1-dependent histone modifications (H2B monoubiquitylation via Rad6, H3K36me2 via Set2) are required at different snoRNA loci. At some snoRNAs, Rad6 function in 3'-end formation is largely independent of its H2B ubiquitylation activity.\",\n      \"method\": \"High-density tiling arrays (transcriptome-wide), ChIP, genetic deletions, epistasis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide tiling array analysis plus targeted ChIP and genetics, single lab\",\n      \"pmids\": [\"23109428\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PAF1 is the core subunit of the conserved RNA Pol II-associated PAF1 complex (PAF1C), which travels with Pol II through the transcription cycle and regulates promoter-proximal pausing (by recruiting Integrator-PP2A and restraining super elongation complex access), transcription elongation, histone modifications (H3K4 methylation via MLL1/Set1; H2B ubiquitylation via Rtf1-Rad6 interaction), chromatin structure (nucleosome turnover), 3'-end processing/termination of mRNAs, snoRNAs, and pervasive transcripts (via Cft1 and Integrator recruitment), and epigenetic silencing (preventing RNAi-directed heterochromatin spreading); additionally, PAF1 physically interacts with Oct3/4 to maintain embryonic stem cell self-renewal and, independently of PAF1C, forms a sub-complex with PHF5A and DDX3 to regulate Nanog expression in cancer stem cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PAF1 is the core subunit of the conserved RNA polymerase II-associated PAF1 complex (PAF1C; Paf1, Ctr9, Cdc73/parafibromin, Rtf1, Leo1), which travels with Pol II across promoters and coding regions of active genes and couples transcription elongation to chromatin modification and RNA 3'-end processing [#0, #1, #2, #3]. Structurally, PAF1 nucleates assembly through a tightly intertwined Ctr9/Paf1 heterodimer and a Paf1/Leo1 heterodimer that together bind histone H3, the octamer, and the nucleosome; loss of the Ctr9-Paf1 interface abolishes complex assembly and histone H3 methylation in vivo [#8, #17]. PAF1C directs co-transcriptional histone marks—H3K4 methylation via MLL1/Set1 and Rtf1-stimulated Rad6-dependent H2B K123 ubiquitylation—and modulates nucleosome dynamics and recruitment of Spt6/FACT during active transcription [#4, #7, #17, #23]. In metazoans PAF1 is a central regulator of Pol II promoter-proximal pausing, restraining release into gene bodies by limiting super elongation complex (SEC) access and by recruiting the Integrator-PP2A (INTAC) complex to skew the balance against P-TEFb-driven SPT5 phosphorylation [#10, #21]; this pausing control extends to enhancers, where PAF1 restrains hyperactivation that would otherwise release paused Pol II at target promoters [#13]. PAF1C also promotes 3'-end processing and termination of mRNAs, snoRNAs, and pervasive transcripts (eRNAs/PROMPTs) through interactions with cleavage/polyadenylation factor Cft1 and Integrator [#5, #22, #24], and by ensuring efficient termination and nascent-transcript release it prevents RNAi/piRNA-directed heterochromatin spreading [#11, #12, #15]. Beyond canonical PAF1C functions, PAF1 maintains embryonic stem cell self-renewal through physical interaction with Oct3/4 [#6] and, independently of PAF1C, forms a PHF5A-DDX3 sub-complex that binds the Nanog promoter to drive cancer stem cell programs [#16].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established PAF1 as the defining subunit of a Pol II-associated complex distinct from Srb-mediator, answering whether PAF1 acts on transcription and through what assembly.\",\n      \"evidence\": \"Affinity/TAP purification with mass spectrometry, reciprocal Co-IP, and genetic epistasis with elongation factors in yeast\",\n      \"pmids\": [\"11927560\", \"11884586\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct mechanistic step in elongation not yet defined\", \"Functional consequence on specific histone marks not yet established\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed PAF1C physically travels with Pol II on active genes and influences CTD Ser2 phosphorylation and poly(A) tail length, linking the complex to both elongation and RNA fate.\",\n      \"evidence\": \"ChIP localization, poly(A) tail analysis, and fractionation across subunit-deletion backgrounds in yeast\",\n      \"pmids\": [\"15149594\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Ser2P change is direct or indirect unresolved\", \"Mechanism coupling Paf1C to poly(A) machinery not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Extended PAF1C to humans and tied it to the tumor suppressor parafibromin, connecting the complex to a clinically mutated subunit.\",\n      \"evidence\": \"Reciprocal Co-IP, RNAi, domain-deletion mapping, and CTD phospho-form association in human cells\",\n      \"pmids\": [\"15923622\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Disease-causing mechanism of parafibromin loss not established here\", \"Direct enzymatic activity not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined a metazoan role in chromatin modulation during active transcription, showing PAF1 is required for H3K4me3 and Spt6/FACT recruitment at induced genes.\",\n      \"evidence\": \"RNAi depletion with ChIP, polytene immunofluorescence, and RNA induction assays in Drosophila\",\n      \"pmids\": [\"16354696\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs. indirect effect on H3K4me3 unresolved\", \"Whether PAF1 recruits the methyltransferase directly not shown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Mechanistically linked PAF1C to 3'-end processing via a direct Cft1 interaction, explaining polyadenylation read-through phenotypes.\",\n      \"evidence\": \"Co-IP detecting Cft1-Paf1C interaction and read-through/CTD phospho assays across subunit deletions in yeast\",\n      \"pmids\": [\"18469135\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why interaction is masked on Pol II-bound Paf1C not fully explained\", \"Generality across genes not tested genome-wide here\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Connected PAF1 to pluripotency, showing it interacts with Oct3/4 and sustains ESC self-renewal.\",\n      \"evidence\": \"Co-IP, knockdown/knockout ESCs, flow cytometry, and pluripotency gene expression analysis\",\n      \"pmids\": [\"19821493\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the Oct3/4 effect requires PAF1C integrity not resolved\", \"Single lab; direct chromatin targets at pluripotency genes not mapped\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linked PAF1 to chromatin remodeling output by showing it supports MLL1-dependent H3K4 methylation and CHD1 nuclear localization in cancer cells.\",\n      \"evidence\": \"siRNA knockdown, Co-IP, confocal co-localization, MNase digestion, and rescue in pancreatic cancer cells\",\n      \"pmids\": [\"22046413\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Directness of PAF1-MLL1 regulation not established\", \"Single lab and cell-type specific\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Generalized PAF1C 3'-processing function to snoRNAs, showing locus-specific dependence on distinct PAF1-controlled histone marks acting with Nrd1/Nab3.\",\n      \"evidence\": \"Transcriptome-wide tiling arrays, ChIP, and epistasis with deletion strains in yeast\",\n      \"pmids\": [\"23109428\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Basis of locus-specific mark requirement unexplained\", \"Some Rad6 effects uncoupled from H2Bub mechanistically unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Provided structural basis for assembly and nucleosome engagement, defining the PAF1/LEO1 heterodimer and CTR9 as scaffold.\",\n      \"evidence\": \"X-ray crystallography of human PAF1/LEO1 plus in vitro histone/nucleosome binding assays\",\n      \"pmids\": [\"24038468\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of nucleosome binding in vivo not shown\", \"Full-complex architecture not resolved here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Placed PAF1 in an H2BK34ub-dependent positive feedback loop stabilizing chromatin factors and pTEFb during early elongation.\",\n      \"evidence\": \"Co-IP binary-interaction mapping, ChIP-seq, siRNA, and Pol II processivity assays\",\n      \"pmids\": [\"24837678\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs. cooperative recruitment not fully separated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established PAF1 as a conserved regulator of promoter-proximal pausing that restrains SEC-driven pause release, distinguishing pausing control from elongation per se.\",\n      \"evidence\": \"siRNA depletion with GRO-seq, ChIP-seq, and RNA-seq in human cells\",\n      \"pmids\": [\"26279188\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PAF1 limits SEC recruitment mechanistically not fully defined here\", \"Locus determinants of pausing sensitivity unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined a chromatin-protective role in which PAF1C-driven termination and transcript release prevent RNAi-directed and spreading heterochromatin.\",\n      \"evidence\": \"Genetic screens, heterochromatin reporters, RNA-seq, ChIP/ChIP-exo, and histone turnover assays in fission yeast\",\n      \"pmids\": [\"25807481\", \"26518661\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular step coupling release to RNAi suppression not fully resolved\", \"Relevance to metazoan heterochromatin not tested here\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Distinguished elongation from RNA-fate roles by showing Paf1 occupancy is dynamic and promoter-tuned, coupling high occupancy to nuclear export.\",\n      \"evidence\": \"NET-seq at nucleotide resolution with yeast genetics across mutant strains\",\n      \"pmids\": [\"28190769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking Paf1 level to export factor loading not defined\", \"How promoters set Paf1 occupancy unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended PAF1 pausing control to enhancers, showing it restrains enhancer hyperactivation that drives pause release at cognate promoters.\",\n      \"evidence\": \"ChIP-seq, CRISPR enhancer knockout, and GRO-seq in human cells\",\n      \"pmids\": [\"28860207\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PAF1 represses enhancer activity mechanistically not defined\", \"Selectivity for enhancer subsets unexplained\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated conservation of PAF1's antagonism of small-RNA-directed silencing, here against PIWI/piRNA pathways downstream of initial silencing.\",\n      \"evidence\": \"RNAi with piRNA-targeted reporters and transposable-element expression in Drosophila OSS cells\",\n      \"pmids\": [\"28844648\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single model and lab\", \"Precise step downstream of PIWI not pinpointed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revealed a PAF1C-independent oncogenic function: a PAF1-PHF5A-DDX3 sub-complex binds the Nanog promoter to sustain cancer stem cells.\",\n      \"evidence\": \"Co-IP/MS, ChIP-seq, CRISPR KO, shRNA, orthotopic tumor models, and DDX3 inhibitor in pancreatic CSCs\",\n      \"pmids\": [\"32781084\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of the sub-complex unknown\", \"Single lab; generality across tumor types untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Implicated PAF1C in selectively transcribing toxic GGGGCC repeat expansions, connecting it to C9orf72 FTD/ALS pathology.\",\n      \"evidence\": \"Unbiased Drosophila genetic screen, RNA/dipeptide quantification, and LEO1 ChIP in human C9+ cells\",\n      \"pmids\": [\"31110321\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Why long repeats are selectively favored not mechanistically resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Uncovered a repressive PAF1C function: promoter-bound Paf1C represses ATG32 to suppress mitophagy until glucose starvation triggers its dissociation.\",\n      \"evidence\": \"ChIP of promoter binding, gene deletions, RT-qPCR, mitophagy assays with mammalian validation\",\n      \"pmids\": [\"31525119\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signal coupling starvation to Paf1C dissociation unknown\", \"Mechanism of repression at the promoter undefined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined an antiviral role and a viral evasion mechanism, with Dengue NS5 binding PAF1C to block its recruitment to STAT2-independent immune genes.\",\n      \"evidence\": \"Co-IP with NS5 domain mapping, PAF1 CRISPR KO, RNA-seq, and viral titer assays\",\n      \"pmids\": [\"34797876\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How NS5 displaces PAF1C from chromatin not resolved\", \"Breadth of immune gene set incompletely mapped\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mechanistically resolved the pausing function via acute degradation, showing PAF1 recruits INTAC to balance against P-TEFb and limits SPT5 hyperphosphorylation.\",\n      \"evidence\": \"Rapid degron, ChIP-seq, GRO-seq, mass spectrometry, and phospho-proteomics in human cells\",\n      \"pmids\": [\"35363521\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PAF1 physically delivers INTAC to paused Pol II not fully defined\", \"Relative contribution of histone-mark loss vs. direct effects unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed PAF1C promotes Integrator-dependent 3' cleavage/termination of pervasive transcripts and dissociates from Integrator upon processive elongation.\",\n      \"evidence\": \"PAF1C depletion/degradation with PRO-seq, ChIP-seq, and Co-IP in human cells\",\n      \"pmids\": [\"35294889\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Switch controlling Integrator handoff at elongation entry undefined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Resolved the molecular basis of PAF1C-driven H2B ubiquitylation, mapping a direct Rtf1-HMD/Rad6 contact that stimulates H2BK123ub.\",\n      \"evidence\": \"Cross-linking/MS, in vitro ubiquitylation, separation-of-function RAD6 alleles, and RNA-seq in yeast\",\n      \"pmids\": [\"37216505\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How H2Bub feeds into downstream elongation/termination not fully traced\", \"Structural model of the Rtf1-Rad6-nucleosome complex absent\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how PAF1 physically integrates its dual roles—delivering INTAC/3'-processing factors versus restraining SEC—into a single dynamic occupancy program across the transcription cycle, and how PAF1C-independent sub-complexes are partitioned mechanistically.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural model of PAF1 engaging paused vs. elongating Pol II\", \"Determinants partitioning PAF1 between PAF1C and PHF5A-DDX3 sub-complexes unknown\", \"How environmental/promoter signals set Paf1 occupancy is undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [10, 13, 19, 21]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [8, 17]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [5, 21, 22, 23]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [8, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 4, 6]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [2, 4]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [2, 11, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 10, 13, 21]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [4, 7, 11, 17, 23]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [5, 22, 24]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 16]}\n    ],\n    \"complexes\": [\"PAF1 complex (PAF1C)\", \"PAF1-PHF5A-DDX3 sub-complex\"],\n    \"partners\": [\"CTR9\", \"LEO1\", \"CDC73\", \"RTF1\", \"CFT1\", \"OCT4\", \"RAD6\", \"PHF5A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}